STANFORD, Calif.--(BUSINESS WIRE)--If every person with juvenile diabetes lived five extra years because of a new stem-cell treatment, would that make California’s $3 billion investment in stem cell research worthwhile? What if heart attacks caused less damage to the heart, or Alzheimer’s disease struck at age 75 instead of 70?
